M. Graciotti

Type de document

Articles (6) Recensions (2)

Co-auteur

Date

Source

Mot-clé

cancer (5) Cancer (5) Vaccines (5) Cancer (5) Treatment (4) Dendritic cells (4) Vaccination (4) Immunotherapy (4) Vaccination (4) Immunotherapy (4) Cells (3) Cancer vaccines (3) toxicité (2) modèle (2) acide (2) méthode (2) Development (2) Control (2) Selection (2) T cells (2) Mice (2) Example (2) Cancer--Patients (2) Agent (Philosophy) (2) Toxicology (2) roman (2) administration (1) puits (1) véhicule (1) temps (durée) (1)

Documents écrit par M. Graciotti (6) | parle de M. Graciotti (0)

Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.
H. Fritah et al. (21 avr. 2023)
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
M. Graciotti et al. (2 juin 2020)
Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform.
R. Ahmed et al. (2020)
Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
S. Martin Lluesma et al. (23 nov. 2018)
A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.
A. Mookerjee et al. (2018)
The era of bioengineering: how will this affect the next generation of cancer immunotherapy?
M. Graciotti et al. (19 juin 2017)